Lonafarnib for treating progeria and progeroid laminopathies [ID3867]
Awaiting development [GID-HST10039] Expected publication date: TBC
Awaiting development [GID-HST10039] Expected publication date: TBC
Awaiting development [GID-HST10020] Expected publication date: TBC
Awaiting development [GID-HST10022] Expected publication date: TBC
Awaiting development [GID-HST10049] Expected publication date: TBC
Awaiting development [GID-DG10064] Expected publication date: TBC
Awaiting development [GID-HST10032] Expected publication date: TBC
Awaiting development [GID-HST10046] Expected publication date: 15 December 2022
We are listening to your views on this Diagnostics guidance. Comments close 25 August 2022.